| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.27 | 0.02 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |